Last reviewed · How we verify
2% Taurolidine Lock
2% Taurolidine Lock is a Small molecule drug developed by Stanley Dudrick's Memorial Hospital. It is currently FDA-approved.
2% Taurolidine Lock, marketed by Stanley Dudrick's Memorial Hospital, is a catheter lock solution currently available in the market. The drug's key composition patent is set to expire in 2028, providing a period of exclusivity that supports its competitive position. The primary risk is the potential for increased competition once the patent expires.
At a glance
| Generic name | 2% Taurolidine Lock |
|---|---|
| Sponsor | Stanley Dudrick's Memorial Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age (PHASE4)
- Lock sOlutiOnS for Epicutaneo-caval Catheters in Neonates: a "LOOSEN" Pilot Study
- Comparison of a TauroLock™ Based Regimen to 4% Citrate as Lock Solution in Tunneled Haemodialysis Catheters for the Prevention of Bacteraemia and Dysfunction (PHASE4)
- Management of Tunneled Catheter Thrombosis in Hemodialysis Patients: Prospective Study From Qatar (PHASE4)
- Clinical Trial Comparing Catheter Lock Solutions TaurolockTMHep 100 and Heparin 100 IE/ml. (PHASE4)
- Taurolidine Lock in Long Term Parenteral Nutrition (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 2% Taurolidine Lock CI brief — competitive landscape report
- 2% Taurolidine Lock updates RSS · CI watch RSS
- Stanley Dudrick's Memorial Hospital portfolio CI
Frequently asked questions about 2% Taurolidine Lock
What is 2% Taurolidine Lock?
Who makes 2% Taurolidine Lock?
What development phase is 2% Taurolidine Lock in?
Related
- Manufacturer: Stanley Dudrick's Memorial Hospital — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing